Alloreactive CD8 T Cell Tolerance Requires Recipient B Cells, Dendritic Cells, and MHC Class II
- 1 July 2008
- journal article
- Published by Oxford University Press (OUP) in The Journal of Immunology
- Vol. 181 (1) , 165-173
- https://doi.org/10.4049/jimmunol.181.1.165
Abstract
Allogeneic bone marrow chimerism induces robust systemic tolerance to donor alloantigens. Achievement of chimerism requires avoidance of marrow rejection by pre-existing CD4 and CD8 T cells, either of which can reject fully MHC-mismatched marrow. Both barriers are overcome with a minimal regimen involving anti-CD154 and low dose (3 Gy) total body irradiation, allowing achievement of mixed chimerism and tolerance in mice. CD4 cells are required to prevent marrow rejection by CD8 cells via a novel pathway, wherein recipient CD4 cells interacting with recipient class II MHC tolerize directly alloreactive CD8 cells. We demonstrate a critical role for recipient MHC class II, B cells, and dendritic cells in a pathway culminating in deletional tolerance of peripheral alloreactive CD8 cells.Keywords
This publication has 48 references indexed in Scilit:
- Peripheral deletional tolerance of alloreactive CD8 but not CD4 T cells is dependent on the PD-1/PD-L1 pathwayBlood, 2008
- HLA-Mismatched Renal Transplantation without Maintenance ImmunosuppressionNew England Journal of Medicine, 2008
- Allopeptide‐Specific CD4+ T Cells Facilitate the Differentiation of Directly Alloreactive Graft‐Infiltrating CD8+ T CellsAmerican Journal of Transplantation, 2007
- A Novel Pathway of Antigen Presentation by Dendritic and Endothelial Cells: Implications for Allorecognition and Infectious DiseasesTransplantation, 2006
- TACI-BLyS signaling via B-cell–dendritic cell cooperation is required for naive CD8+ T-cell priming in vivoBlood, 2006
- Tolerance induction in clinical transplantationTransplant Immunology, 2004
- Mechanism of Action of Donor-Specific Transfusion in Inducing ToleranceJournal of the American Society of Nephrology, 2004
- Peripheral Expression of Self-MHC-II Influences the Reactivity and Self-Tolerance of Mature CD4+ T CellsImmunity, 2002
- RESTING B CELLS AS TOLEROGENS IN VIVO BUT ONLY FOR MINOR HISTOCOMPATIBILITY ANTIGENSTransplantation, 1997
- Mice Lacking the MHC Class II Transactivator (CIITA) Show Tissue-Specific Impairment of MHC Class II ExpressionPublished by Elsevier ,1996